Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the ...

Researchers have produced a review of chromatography media and purification processes for handling complex and super-large ...

The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation SAN DIEGO, CA - February 18, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" ...

Greatwall, a conserved MAST-like kinase with crucial mitotic entry functions, is curiously absent in worms. Here, the single ...

The preliminary data presented in this manuscript seem valuable. The data are currently incomplete and there are numerous technical concerns, some of which may arise from insufficient description of ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Purgatory is not a second-chance for damned souls to repent. Instead it is a state of cleansing and purification for souls destined for heaven. Also Purgatory is not a means to earn our way to ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Laboratory Technical Project ...

Q4 2024 Earnings Call Transcript February 13, 2025 Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $2 ...

Bio-Rad Laboratories Inc (NYSE:BIO). reported its fourth-quarter 2024 earnings, revealing a slight miss on revenue expectations, with net sales of $668 million compared to a forecast of $681.29 ...